Your browser doesn't support javascript.
loading
Pioneering, chromatin remodeling, and epigenetic constraint in early T-cell gene regulation by SPI1 (PU.1).
Ungerbäck, Jonas; Hosokawa, Hiroyuki; Wang, Xun; Strid, Tobias; Williams, Brian A; Sigvardsson, Mikael; Rothenberg, Ellen V.
  • Ungerbäck J; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California 91125, USA.
  • Hosokawa H; Division of Molecular Hematology, Lund University, SE-221 84 Lund, Sweden.
  • Wang X; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California 91125, USA.
  • Strid T; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California 91125, USA.
  • Williams BA; Division of Molecular Hematology, Lund University, SE-221 84 Lund, Sweden.
  • Sigvardsson M; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California 91125, USA.
  • Rothenberg EV; Division of Molecular Hematology, Lund University, SE-221 84 Lund, Sweden.
Genome Res ; 28(10): 1508-1519, 2018 10.
Article en En | MEDLINE | ID: mdl-30171019
ABSTRACT
SPI1 (also known as PU.1) is a dominant but transient regulator in early T-cell precursors and a potent transcriptional controller of developmentally important pro-T-cell genes. Before T-lineage commitment, open chromatin is frequently occupied by PU.1, and many PU.1 sites lose accessibility when PU.1 is later down-regulated. Pioneering activity of PU.1 was tested in this developmentally dynamic context by quantitating the relationships between PU.1 occupancy and site quality and accessibility as PU.1 levels naturally declined in pro-T-cell development and by using stage-specific gain- and loss-of-function perturbations to relate binding to effects on target genes. PU.1 could bind closed genomic sites, but rapidly opened many of them, despite the absence of its frequent collaborator, CEBPA. RUNX motifs and RUNX1 binding were often linked to PU.1 at open sites, but highly expressed PU.1 could bind its sites without RUNX1. The dynamic properties of PU.1 engagements implied that PU.1 binding affinity and concentration determine its occupancy choices, but with quantitative trade-offs for occupancy between site sequence quality and stage-dependent site accessibility in chromatin. At nonpromoter sites, PU.1 binding criteria were more stringent than at promoters, and PU.1 was also much more effective as a transcriptional regulator at nonpromoter sites where local chromatin accessibility depended on the presence of PU.1. Notably, closed chromatin presented a qualitative barrier to occupancy by the PU.1 DNA-binding domain alone. Thus, effective pioneering at closed chromatin sites also depends on requirements beyond site recognition, served by non-DNA-binding domains of PU.1.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cromatina / Transactivadores / Proteínas Proto-Oncogénicas Tipo de estudio: Prognostic_studies / Qualitative_research Límite: Animals Idioma: En Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cromatina / Transactivadores / Proteínas Proto-Oncogénicas Tipo de estudio: Prognostic_studies / Qualitative_research Límite: Animals Idioma: En Año: 2018 Tipo del documento: Article